Table 5.
Growth or no growth of the affected eye.
| Affected side | Follow‐up (years) | Growth unaffected/largest side | Growth affected/smallest side | Growth/no growth |
|---|---|---|---|---|
| PFV | ||||
| OS | 5.2 | 2.30 | 0.20* | No |
| OS | 3.5 | 4.80 | 5.00 | Yes |
| OS | 3.6 | 2.20 | 0.20 | No |
| OD | 1.8 | 2.70 | 0.80 | Minimal** |
| OD | 2.2 | 1.70 | 2.50 | Yes |
| OD | 4.0 | 3.10 | 0.90 | Minimal |
| OS | 2.6 | 2.40 | −2.80 | No |
| OS | 1.3 | 3.50 | 3.10 | Yes |
| OS | 5.1 | 2.10 | 1.10 | Minimal |
| OD | 1.4 | 2.40 | 1.60 | Minimal |
| COMB | ||||
| ODS | 1.3 | 4.30 | 3.80 | Yes/ yes |
| OS | 2.8 | 0.40 | 0.90 | Yes |
| OD | 3.3 | 1.50 | −8.20 | No |
| OS | 1.3 | 2.20 | −4.10 | No |
| OS | 3.1 | 5.40 | −2.70 | No |
| OS | 1.0 | 0.90 | 0.00 | No |
| OD | 2.8 | 0.90 | −0.10 | No |
| OS | 2.2 | 1.90 | 1.90 | Yes |
| ODS | 3.0 | 3.50 | 2.80 | Yes/ yes |
| SEC | ||||
| OS | 3.8 | 0.90 | −1.60 | No |
| ASD | ||||
| ODS | 5.0 | 3.30 | 6.20 | Yes/yes |
| ODS | 0.4 | 0.70 | 0.00 | Yes/no |
| OD | 1.4 | 1.10 | 0.80 | Yes |
| OS | 2.5 | 1.00 | −0.80 | No |
| OS | 1.5 | 0.70 | 0.60 | Yes |
| ODS | 3.0 | 5.20 | 2.90 | Yes/yes |
| OFCD | ||||
| ODS | 0.8 | 1.60 | 2.30 | Yes/yes |
| OD | 3.5 | 2.30 | 4.50 | Yes |
| OD | 1.7 | 2.80 | 0.00 | No |
| OD | 2.0 | 4.00 | −0.90 | No |
| OS | 1.6 | 1.40 | 0.40 | Minimal |
| OS | 5.1 | 1.30 | 1.10 | Yes |
| OS | 3.4 | 2.10 | 0.50 | Minimal |
| OS | 4.1 | 1.50 | 1.10 | Yes |
| OD | 2.2 | 1.20 | 1.90 | Yes |
| OS | 0.5 | 3.20 | 0.70 | Minimal |
| REMNANT | ||||
| ODS | 2.5 | 1.50 | −2.00 | Yes/no |
| OD | 2.1 | 3.10 | −2.20 | No |
| OD | 5.7 | 2.20 | 2.00 | Yes |
| OD | 3.8 | 0.60 | 3.80 | Yes |
| OS | 3.3 | 6.60 | 4.40 | Yes |
*
Only changes of more than 0.2 mm were noted as possible growth.
**
If growth was minimal compared to the growth of the healthy side, this was marked as ‘minimal’ growth.